|
As reported by a field clinical specialist (fcs), during a tavr procedure with a 26mm sapien 3 valve in the aortic position, the 26mm certitude balloon ruptured during deployment.The fcs advised that the ruptured was very difficult to remove.The balloon and sheath had to be removed together and a new delivery balloon and sheath had to be inserted and used to post dilate the valve.There were no issues at the time of this note.Upon follow up, the fcs advised that the balloon was torn.The event was at the last 1 or 2ccs of balloon inflation.An attempt was made to remove the delivery system through the sheath, but the balloon wings would not allow.The entire system, delivery and sheath were removed together.No instruments were used to remove the balloon cover.No extra volume added to the balloon prior to the inflation.The speed of the inflation technique was slow.There was no leak in the delivery system noticed.Blood was seen in the syringe when negative pressure was pulled in the inflation device.There was no difficulty with the valve alignment.There was difficulty withdrawing the delivery system.The withdrawal difficulty was experienced after the balloon ruptured.The certitude delivery system and sheath were removed together.There was damage observed on the balloon shaft.Upon inspection after removal, the area of leakage was a full circumferential tear.There was no injury or complication related to this event.The patient's final outcome was stable.The perceived root cause of the event was that the operator was pulling extremely hard on the delivery system during inflation.The device was discarded by hospital staff.
|
|
A supplemental mdr is being submitted due to engineering evaluation findings, sections g6, h2, h6: component codes, impact code, type of investigation, investigation findings, investigation conclusions and h11 has been added.The events reported are anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure mode is not required at this time.The device was not returned for evaluation.Due to the unavailability of the complaint device, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.The complaints for balloon burst inability to withdraw system through sheath were unable to be confirmed as the complaint unit was not returned and no relevant procedural imagery was provided.Available information suggests patient factors (calcification) likely contributed to the event based on the provided 3mensio imagery.The presence of calcification can create a challenging anatomy for balloon inflation.While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.As the balloon was burst, the altered balloon profile could have made it more susceptible to catch on patient vasculature and/or the sheath tip, which would have then led to the experienced retrieval difficulty.As such, available information suggests that procedural factors (withdrawal of burst balloon) likely contributed to the event.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of this adverse event is not required at this time.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
|